why choose us

300×250 Ad Slot

Research Article: HYPofractionated Adjuvant RadioTherapy in 1 versus 2 weeks in high-risk patients with breast cancer (HYPART): a non-inferiority, open-label, phase III randomised trial

Date Published: 2024-01-02

No summary available.

300×250 Ad Slot